Showing 3,821 - 3,840 results of 9,864 for search '"drug"', query time: 0.12s Refine Results
  1. 3821

    Role of Plasmapheresis in the Treatment of Severe Pruritus in Pregnant Patients with Primary Biliary Cirrhosis: Case Reports by Alallam Alallam, David Barth, E Jenny Heathcote

    Published 2008-01-01
    “…Several therapeutic modalities have been used to control itching caused by cholestasis, with variable responses. Drug therapies are ill-advised, particularly in early pregnancy. …”
    Get full text
    Article
  2. 3822

    Zolpidem: Efficacy and Side Effects for Insomnia by Amber N. Edinoff, Natalie Wu, Yahya T. Ghaffar, Rosemary Prejean, Rachel Gremillion, Mark Cogburn, Azem A. Chami, Adam M. Kaye, Alan D. Kaye

    Published 2021-06-01
    “…Zolpidem is a helpful drug for the treatment of insomnia in conjunction with cognitive-behavioral therapy. …”
    Get full text
    Article
  3. 3823
  4. 3824
  5. 3825

    Outpatient Intravenous Antibiotic Therapy: The Vancouver Hospital experience by Grant Stiver, Amy Wai, Lynne Chase, Luciana Frighetto, Carlo Marra, Peter Jewessen

    Published 2000-01-01
    “…There were 15 adverse drug reactions overall in the total of 2534 patient-days of therapy over 18 months. …”
    Get full text
    Article
  6. 3826

    A versatile platform based on matrix metalloproteinase-sensitive peptides for novel diagnostic and therapeutic strategies in arthritis by Mingyang Li, Tao Deng, Quan Chen, Shenghu Jiang, Hang Li, Jiayi Li, Shenglan You, Hui-qi Xie, Bin Shen

    Published 2025-05-01
    “…Specifically, the ultra-sensitive MSP diagnostic probes could significantly advance the early diagnosis and detection of osteoarthritis (OA), while MSP-based drug carriers for rheumatoid arthritis (RA) can intelligently release anti-inflammatory drugs effectively during flare-ups, or even before symptoms manifest. …”
    Get full text
    Article
  7. 3827

    The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma by O. A. Storonova, A. V. Paraskevova, A. A. Makushina

    Published 2024-08-01
    “…The addition of UDCA drugs to the basic therapy is pathogenetically justified in patients with GERD in the presence of duodenogastroesophageal reflux. …”
    Get full text
    Article
  8. 3828

    Identification and characterization of the functional tetrameric UDP-glucose pyrophosphorylase from Klebsiella pneumoniae by Isabel Ramón Roth, Pavel Kats, Timm Fiebig, Françoise Routier, Roman Fedorov, Larissa Dirr, Jana I. Führing

    Published 2025-02-01
    “…UGPs have, therefore, gained attention as anti-bacterial drug target candidates, prompting us to study their structure-function relationships to provide a basis for the rational development of specific inhibitors. …”
    Get full text
    Article
  9. 3829

    Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center by Roxana Matran, Andra-Mihaela Diaconu, Andreea Maria Iordache, Irina Dijmărescu, Alexandra Coroleucă, Daniela Păcurar, Cristina Becheanu

    Published 2025-01-01
    “…<b>Conclusions</b>: AEs were observed in approximately half of the study cohort, with anti-drug antibody formation emerging as the most frequent complication. …”
    Get full text
    Article
  10. 3830

    Autologous Fat Grafting Reduces Pain in Irradiated Breast: A Review of Our Experience by Fabio Caviggioli, Luca Maione, Francesco Klinger, Andrea Lisa, Marco Klinger

    Published 2016-01-01
    “…Forty-eight in 59 patients stopped their analgesic drug therapy. Controls reported a mean ± SD decrease of pain of 1.14 ± 2.72. …”
    Get full text
    Article
  11. 3831
  12. 3832

    Impact of time-varying exposure on estimated effects in observational studies using routinely collected data: protocol for a cross-sectional study by Ling Li, Xin Sun, Jing Tan, Mei Liu, Wen Wang, Kevin Lu, Guowei Li, Jiayue Xu, Jeff Jianfei Guo

    Published 2022-07-01
    “…Introduction Time-varying exposure is an important issue that should be addressed in longitudinal observational studies using routinely collected data (RCD) for drug treatment effects. How well investigators designed, analysed and reported time-varying exposure, and to what extent the divergence that can be observed between different methods used for handling time-varying exposure in these studies remains uncertain. …”
    Get full text
    Article
  13. 3833

    BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report by Yasar Subutay Peker, Mehmet Fatih Can, Ismail Hakki Ozerhan, Gokhan Yagci, Nazif Zeybek, Kutan Kavakli, Sedat Gurkok, Alper Gozubuyuk, Onur Genc, Gokhan Erdem, Ahmet Ozet, Mustafa Gerek, Yusuf Peker

    Published 2018-01-01
    “…A remarkable response was achieved with vemurafenib treatment in which the drug resistance occurred approximately in the sixth month. …”
    Get full text
    Article
  14. 3834

    Metabolic syndrome and pancreatic lesions by O. S. Shifrin, I. A. Sokolina, A. E. Leonovich, M. A. Ashitko, T. L. Lemina, A. V. Korolyov

    Published 2013-05-01
    “…The issue of application of new phospholipid drug Resalut in patients with SP, associated to hepatic steatosis and lipidemia is discussed. …”
    Get full text
    Article
  15. 3835

    Bioanalytical method development, in-vivo pharmacokinetic evaluation, ex-vivo platelet aggregation inhibition activity of a novel solid dispersion formulation of ticagrelor by Abhishek Srivastava, Abhishek Srivastava, Simrata Bedi, Abhishesh Kumar Mehata, Datta Maroti Pawde, Ketan Vinayakrao Hatware, Mohammad Ahmad Khan, M. S. Muthu, Uma Bhandari

    Published 2025-02-01
    “…BackgroundTicagrelor, a potential antithrombotic drug indicated for cardiovascular events with acute coronary syndrome, has been restricted from its oral use due to poor aqueous solubility. …”
    Get full text
    Article
  16. 3836
  17. 3837

    Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants by Shujun Lin, Wenshan Lin, Chunling Liao, Tianbiao Zhou

    Published 2020-01-01
    “…Renal damage caused by drug toxicity is becoming increasingly common in the clinic. …”
    Get full text
    Article
  18. 3838

    Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Po... by Masayuki Mori, Kenji Sakata, Junichiro Yokawa, Chiaki Nakanishi, Kota Murai, Hirofumi Okada, Masaya Shimojima, Shohei Yoshida, Kazuaki Yoshioka, Yoh Takuwa, Kenshi Hayashi, Masakazu Yamagishi, Masa-aki Kawashiri

    Published 2020-01-01
    “…Although Synergy™ and Promus PREMIER™ share an identical stent material and drug elution (everolimus), they use different drug carrier systems: biodegradable abluminal coating polymer or durable conformal coating polymer, respectively. …”
    Get full text
    Article
  19. 3839

    New Approach of the Oxidant Peroxo Method (OPM) Route to Obtain Ti(OH)4 Nanoparticles with High Photocatalytic Activity under Visible Radiation by André E. Nogueira, Lucas S. Ribeiro, Luiz F. Gorup, Gelson T. S. T. Silva, Fernando F. B. Silva, Caue Ribeiro, Emerson R. Camargo

    Published 2018-01-01
    “…Therefore, this work describes the preparation and characterization of a Ti(OH)4 catalyst with the modified surface for application in the photodegradation of organic compounds (methylene blue (MB) dye and the drug amiloride (AML)) and in the artificial photosynthesis process. …”
    Get full text
    Article
  20. 3840

    Cytotoxicity Potentials of Eleven Bangladeshi Medicinal Plants by Amina Khatun, Mahmudur Rahman, Tania Haque, Md. Mahfizur Rahman, Mahfuja Akter, Subarna Akter, Afrin Jhumur

    Published 2014-01-01
    “…The quest of anticancer drugs both from natural and synthetic sources is the demand of time. …”
    Get full text
    Article